Business Wire

BRAND-EMBASSY

6.10.2016 12:04:40 CEST | Business Wire | Press release

Share
Avaya Partners with Brand Embassy to Provide Digital Customer Service to Enterprises in Europe

Digital customer service platform, Brand Embassy , has agreed a partnership with global technology and CRM specialists, Avaya , in order to better address a major shift to digital customer interactions in Europe.

The partnership was announced at the Avaya Forum 2016, which took place in Prague in September, by Brand Embassy CEO, Vit Horky, and Avaya Global Account Manager, Patrik Monari.

“10 years ago there was no web chat, smartphone apps, social media, and very little email. Today, digital interactions account for over 35% of all customer service interactions and, at the current rate, will overtake voice in two years’ time. We approached Brand Embassy, a recognised leader in the digital customer care segment, to augment our offering for our largest customers in the European region,” states Patrik Monari, Avaya Global Account Manager

“People use mobile apps and connect with brands on facebook every single day. Done right, Omnichannel customer service can result in higher customer satisfaction, more efficient employees, accelerated response and higher conversion rates. Avaya is a global leader in technology and CRM software, and we’re delighted to commence such a mission-critical cooperation with them,” states Vit Horky , Brand Embassy Founder & CEO

Brand Embassy, whose development team is based in Prague, Czech Republic, is cooperating with Avaya to deliver a truly omnichannel experience in customer service for Enterprise and high-growth customers, mainly from the telco, banking and eCommerce sectors.

Notes to Editors

About Brand Embassy

The top-rated social customer service platform, Brand Embassy , helps companies acquire and retain customers through digital customer service at scale. Our clients are major Enterprises and high-growth companies from the telco, banking and eCommerce sectors, such as: T-Mobile, Telenor, Telefonica, Vodafone, Home Credit, Societe Generale, GE Money, Samsung, Mall.cz, Zoot. Brand Embassy is headquartered in London, with offices in Prague and San Francisco. See more, here

About Avaya

Avaya Inc . is an American multinational technology company headquartered in Santa Clara, California that specializes in Internet telephony, wireless data communications, and Customer relationship management (CRM) software, and provides business communication solutions for customer and team engagement. Avaya currently services organizations at over 1 million customer locations worldwide with operations divided globally in 5 regions. See more, here

Contact:

Brand Embassy
Brendan Donnellan
Marketing Director
+420734819716
Brendan.donnellan@brandembassy.com

Link:

ClickThru

Social Media:

https://www.facebook.com/likebrandembassy

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

MANE Selects Kinaxis to Strengthen Global Planning Capabilities29.6.2026 13:00:00 CEST | Press release

Kinaxis Maestro™ platform to provide the digital foundation to strengthen MANE’s global planning capabilities and support its continued planning transformation Kinaxis®(TSX:KXS), a global leader in end-to-end supply chain planning and orchestration, today announced that MANE, one of the top five leading organizations worldwide in the flavours and fragrances industry, has selected Kinaxis to modernize its planning capabilities as it accelerates global growth as part of a broader enterprise-wide transformation initiative. Headquartered in the south of France, with a significant global footprint spanning multiple regions and customers across international markets, MANE is known for its innovation, technical expertise and strong commitment to sustainability. The company is investing in more connected, end-to-end planning capabilities to support continued growth and increasing operational complexity worldwide. Following an extensive evaluation process with major competitors in the market, M

From Abu Dhabi to Imola: A2RL Expands Internationally with Historic Autonomous Racing Debut at Iconic Italian Track29.6.2026 12:12:00 CEST | Press release

A2RL’s first international race marks a major step towards its ambition to become the world’s first international championship for fully autonomous racecarsUp to 5 teams including TUM, PoliMOVE, Unimore, Kinetiz and Constructorselected from the 2025 season will compete in the world’s first autonomous multi-car race in EuropeA2RL engaged Italy’s motorsport, engineering and student communities through Motor Valley Fest and a university roadshow ahead of the raceFollowing European debut at Imola, the 2026 season will conclude at Yas Marina Circuit in Abu Dhabi The Abu Dhabi Autonomous Racing League, A2RL, will make its international racing debut on 5 September 2026 in Imola, Italy, bringing up to 5 fully autonomous racecars based on the Dallara Super Formula SF23 to one of the world’s most iconic and demanding racing circuits. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629726789/en/ From Abu Dhabi to Imola: A2RL Expands

Philip Morris International and Maestro Andrea Bocelli Present “Believe. Further”29.6.2026 12:00:00 CEST | Press release

A new platform for dialogue on progress, reflecting a mutual commitment to advancing positive change Philip Morris International (PMI) (NYSE: PM) and Maestro Andrea Bocelli today presented “Believe. Further”, a multi-year platform designed to engage audiences in a broader conversation on progress and positive change. The launch took place at the Torre dell’Arsenale in Venice, where heritage and forward movement meet, a fitting setting for two voices on a similar path. What do you do when the world has already decided what you are? “Believe. Further” begins from that question. It is built around a shared belief in progress and a shared conviction in transformation. At a time when science and technology allow better choices, it brings together two voices that, independently and in parallel, are undergoing a change in motion, and invites the beginning of a different conversation with society at large. Maestro Bocelli’s journey has been defined by belief. From the beginnings of his career

Doubtless Pet Care Launches to Provide Peace of Mind to Pet Parents and Help Their Pets Live Happier, Healthier Lives29.6.2026 10:15:00 CEST | Press release

Doubtless combines industry-leading pet insurance with innovative care solutions, protecting more than 6 million pets across 10 global markets Doubtless launches today with the goal of helping more pet parents across the world access quality care for the pets they love. The company brings together a leading global portfolio of pet insurance brands with a growing range of connected solutions designed to support pet parents at every stage of their pet’s life. With over 4,000 employees, Doubtless insures 6 million pets across 10 markets in North America, Europe and the United Kingdom. “Uncertainty about the financial commitments associated with having a pet should never keep families from experiencing the joy of a life with pets,” said Dirk Beeckman, CEO of Doubtless. “By harnessing the power of our international footprint, we are building on our leadership in pet insurance to create a global suite of solutions for pet parents, veterinarians and industry partners that makes pet care easie

Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 09:19:00 CEST | Press release

Phase 1 study demonstrated pharmacokinetic (PK) equivalence between SB27 and Keytruda; Phase 3 study demonstrated equivalent objective response rate (ORR) at Week 24Phase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patie

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye